• We specialize in small molecule inhibitors, agonists, antagonists and screening libraries!
Search Site
Home >> Signaling Pathways >> Proteases >> Cathepsin >> Cathepsin G Inhibitor I
Related Products
Cathepsin G Inhibitor ICathepsin G inhibitor

Cathepsin G Inhibitor I

Catalog No. A8174
Size Price Stock Qty
10mM (in 1mL DMSO) $360.00 In stock
Evaluation Sample $28.00 In stock
1mg $80.00 In stock
5mg $160.00 In stock
10mg $250.00 In stock

Tel: +1-832-696-8203

Email: sales@apexbt.com

Worldwide Distributors

Sample solution is provided at 25 µL, 10mM.

Quality Control

Quality Control & MSDS

View current batch:

Chemical structure

Cathepsin G Inhibitor I

Biological Activity

Cathepsin G Inhibitor I is a potent, selective, reversible, competitive, non-peptide inhibitor of cathepsin G.
Targets cathepsins G          
IC50 53nM          

Cathepsin G Inhibitor I Dilution Calculator

Concentration (start)
Volume (start)
Concentration (final)
Volume (final)


Cathepsin G Inhibitor I Molarity Calculator



Chemical Properties

Cas No. 429676-93-7 SDF Download SDF
Chemical Name [2-[3-[(1-benzoylpiperidin-4-yl)-methylcarbamoyl]naphthalen-2-yl]-1-naphthalen-1-yl-2-oxoethyl]phosphonic acid
Canonical SMILES CN(C1CCN(CC1)C(=O)C2=CC=CC=C2)C(=O)C3=CC4=CC=CC=C4C=C3C(=O)C(C5=CC=CC6=CC=CC=C65)P(=O)(O)O
Formula C36H33N2O6P M.Wt 620.64
Solubility >10.4mg/mL in DMSO Storage Store at -20°C
General tips N/A
Shipping Condition N/A

View Related Products By Research Topics


IC50: 53 nM

Cathepsin G (EC, chymotrypsin-like proteinase, neutral proteinase) is an enzymatic protein belonging to the peptidase or protease families. In humans, it is coded by the CTSG gene. Cathepsin G Inhibitor I is a potent, selective, reversible, competitive, non-peptide inhibitor of cathepsin G.

In vitro: Cathepsin G Inhibitor I shows reversible, competitive inhibition with IC50 and Ki values of 53 ± 12 (N = 10) and 63 ± 14 nM (N = 5), respectively. Another attribute of Cathepsin G Inhibitor I relates to its selectivity vs other serine proteases. It weakly inhibits chymotrypsin (Ki = 1.5 ± 0.2 μM), and poorly inhibits (<50% inhibition at 100 μM) thrombin, factor Xa, factor IXa, plasmin, trypsin, tryptase, proteinase 3, and human leukocyte elastase [1].

In vivo: Cathepsin G Inhibitor I is currently in in-vitro investigation and no animal in vivo study is ongoing [1].

Clinical trial: Cathepsin G Inhibitor I is currently in the preclinical development and no clinical trial is ongoing.

[1] Greco MN, Hawkins MJ, Powell ET, Almond HR Jr, Corcoran TW, de Garavilla L, Kauffman JA, Recacha R, Chattopadhyay D, Andrade-Gordon P, Maryanoff BE.  Nonpeptide inhibitors of cathepsin G: optimization of a novel beta-ketophosphonic acid lead by structure-based drug design. J Am Chem Soc. 2002;124(15):3810-1.